about
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279).Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.Tolerance of pelvic organs to radiation treatment for carcinoma of cervix.Evaluation of the status of tuberculosis as part of the clinical case definition of AIDS in India.Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.Platinum-based chemotherapy in metastatic breast cancer: current status.Best practice in primary care pathology: review 4Salvage radiotherapy after high intensity focused ultrasound for prostate cancer.Radiotherapy to patients with artificial cardiac pacemakers.Anaemia is associated with poor overall survival but not with inferior local control in patients with muscle invasive bladder carcinoma treated by radical external beam radiotherapy. A retrospective study.Information needs of Asian and White British cancer patients and their families in Leicestershire: a cross-sectional survey.Denosumab should be the treatment of choice for bisphosphonate refractory hypercalcaemia of malignancy.Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer.Evolution of the treatment paradigm for patients with metastatic castration-resistant prostate cancer.A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy.A self-adaptive case-based reasoning system for dose planning in prostate cancer radiotherapy.Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.Impact of neutropenia on delivering planned chemotherapy for solid tumours.A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer.Cancer patients' anxiety.Age does not influence acute toxicity during radiotherapy dose escalation for prostate cancer.Misconceptions about 'do-not-resuscitate (DNR)' orders in the era of social media.Male cancer patients' attitudes towards female health professionals during urological consultations.Diagnostic radiology for radiotherapist: the case for structured training in cross-sectional imaging (CT and MRI).International register of trial acronyms.The law of unintended consequences.New law on consent will overload seriously ill patientsRe: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur urol 2006;49:54-8Utility of regular serum biochemistry and midstream urine cultures in men undergoing three-dimensional conformal pelvic radiotherapy for prostate cancerProlonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?Cabazitaxel rechallenge at prostate-specific antigen relapse after previous cabazitaxel and docetaxel chemotherapy: case reportAcute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991Sugar-free medicines are counterproductiveRe: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU Guidelines. Eur Urol 2011;59:1009-18The return of the snake oil salesmen: the sequelSome forms of knowledge are more equal than othersMilk and mortality: the potential effects of modern milk productionRe: Michael T. Schweizer, Xian C. Zhou, Hao Wang, et al. The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2014;66:646-52
P50
Q30886900-8A61493D-FEF2-4BCB-95CE-D0101EC745BEQ33419283-37F52187-0DFF-4F0C-9846-1EA102FFE522Q35201750-75478949-1AE8-404B-A01E-913184643FA3Q35522054-14894724-2822-44D8-9528-16DB05C25098Q35567212-164A8AF2-0FE7-481D-9102-7F7CCE7B5202Q35650449-02DF9E14-9311-4AA5-8F2E-F87E50E3DCF9Q35770305-AD98BA9A-A221-419D-940C-F7D34B8C1FEEQ35975718-587CB4D8-B0F6-43FD-99DD-897FF1591158Q36185828-4F5DAACA-5C3F-4283-998F-E19ABA415F83Q36682976-A647B572-00F8-4925-89E9-5A65B2BB9EC6Q36694919-8C4ABF71-973B-4435-AD6B-0C9F2DC50FAAQ37550018-3161DCF9-221B-4337-9FDC-56DDDE824197Q37996104-F7986117-9D16-4A64-A6C4-7759C3A57516Q38166255-8C4EF009-A7DE-48CD-A664-BD7F34C80DC3Q40545094-197221B1-EB0B-4D0D-90CF-A72B2D6D3118Q41646402-1DA0DD82-DBC7-420C-9EE9-C2C56799F4E5Q43198738-AF8917B3-6F72-4AA3-989C-B893CC853797Q45904923-D01CBD82-6DEC-4C8D-B839-9153D28FE502Q46583818-0FD7453C-E16E-4482-A7E7-C065AA6C66F2Q46817819-B5E1B28E-18B6-4642-8AB7-670FC0221AA4Q47995616-4699BC5F-4FD1-4BC5-8DCE-8B5E5BDF4469Q51024702-1AEEDCC6-FDA8-4829-A9AE-323FE35B789EQ51145035-1D513CC4-8273-4BDA-BA6E-94FB0804A3C4Q51454459-5C050E5D-5D4A-4765-9780-39298FA31D57Q51786541-B6C3040C-607C-45B1-88B7-0B6DDFBF19BEQ52947916-E9D2458B-ABB3-45A5-8B00-5F2C8B733323Q53293805-E4A917E0-8A20-4686-BA53-5AE968819F83Q55653529-291F10C0-6419-4B09-8139-AAA21F9C1E0BQ56768163-27628D51-7D81-4CCE-9971-1FFB3FA079B8Q79426085-9933CA89-FE0F-4135-9520-C336B08A031EQ79929143-523DEFCB-9B61-4CF4-A4A3-F4EF0D5D0933Q83242602-F304AED6-EB2C-4710-BDFC-21659A07752FQ83738325-FCDB67CC-4E6A-46B2-BF1B-A7F8C3E5FD97Q84408300-5FEDD763-AC39-4B2F-A463-2EB9911D415FQ84943049-32F04768-D012-4F18-AD92-0E3D62C96E3DQ84978362-2ADF289D-6ECD-418D-9BB2-D5E7EEBB5656Q85014542-393C80FE-084D-4506-9295-1301F7695D4AQ85375570-A0E25869-23E5-4E44-B7CC-D0AFADC5B13DQ86063889-062915FA-ADBC-480C-A82A-EACF7CCC4BD7Q86385616-48D544DC-5C61-4013-A9BD-1C47E160E80F
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0850-5161
@en
name
Santhanam Sundar
@ast
Santhanam Sundar
@en
Santhanam Sundar
@es
Santhanam Sundar
@nl
type
label
Santhanam Sundar
@ast
Santhanam Sundar
@en
Santhanam Sundar
@es
Santhanam Sundar
@nl
prefLabel
Santhanam Sundar
@ast
Santhanam Sundar
@en
Santhanam Sundar
@es
Santhanam Sundar
@nl
P106
P1153
7103328080
P31
P496
0000-0003-0850-5161